BAM
CNMD icon

Belpointe Asset Management’s CONMED CNMD Stock Holding History

Belpointe Asset Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-309
Closed -$32.1K – 1093
2023
Q1 		$32.1K Buy
309
+264
+587% +$25.5K ﹤0.01% 2009
2022
Q4 		$3.99K Buy
+45
New +$3.73K ﹤0.01% 3015

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Belpointe Asset Management's CNMD Position: Q2 2023 in Review

Belpointe Asset Management sold out of CONMED (CNMD) in Q2 2023, closing a stake of 309 shares — an estimated $32.1K sold.

Belpointe Asset Management first reported a position in CNMD in Q4 2022 and held it in 2 quarters. The position peaked at $32.1K in Q1 2023. 263 funds tracked by Wall St. Rank hold CNMD as of Q2 2023.

  • Belpointe Asset Management reported no remaining CONMED position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 309 CONMED shares in Q2 2023, an estimated $32.1K.
  • Belpointe Asset Management first reported a position in CONMED in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's CONMED position peaked at $32.1K in Q1 2023.
  • 263 funds tracked by Wall St. Rank held CONMED as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.